Literature DB >> 7300403

Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy, and surgical therapy.

Z Steiger, R Franklin, R F Wilson, L Leichman, H Seydel, J J Loh, G Vaishamapayan, T Knechtges, I Asfaw, A Dindogru, J C Rosenberg, T Buroker, A Torres, D Hoschner, P Miller, T Pietruk, V Vaitkevicius.   

Abstract

Between April, 1977, and March, 1981, 86 unselected patients with proved squamous cell carcinoma of the esophagus were treated with a combination of chemotherapy and radiotherapy followed by operation whenever feasible. The preoperative chemotherapeutic agents used initially were 5-fluorouracil, and mitomycin C. After December, 1979, cis-platinum was used instead of mitomycin C. Radiotherapy (3,000 rads) of the tumor was begun at the same time as the chemotherapy. An esophagectomy was performed on suitable candidates 3 to 4 weeks after the chemotherapy and radiotherapy were completed. The mucosal lesion disappeared in 69 of the 86 patients, and dysphagia was relieved at least temporarily in 57 of 62 patients. Recurrent dysphagia resulting from fibrosis at the tumor site caused a secondary stenosis in 11 patients. Excellent palliation was obtained in five patients with bronchoesophageal fistulas who had an initial substernal gastric bypass followed by chemotherapy and radiotherapy. Of the 48 patients who had an esophagectomy, 15 (31%) had no tumor in the resected specimen. Eleven of these 15 patients are still alive with no evidence of disease. All patients with a lesion less than 5.0 cm in length had complete regression of the tumor. We believe that this combination of chemotherapy, radiotherapy, and surgical therapy provides excellent palliation, increases resectability, and has a potential for cure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7300403

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

1.  The role of rigid oesophagoscopy in oesophageal carcinoma.

Authors:  A J Ritchie; K McManus; J McGuigan; H M Stevenson; J R Gibbons
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

2.  [Preoperative chemotherapy in esophageal cancer: an advantage or danger for surgical intervention?].

Authors:  P Schlag; R Herrmann; U Raeth; B Lehner; V Schwarz; C Herfarth
Journal:  Langenbecks Arch Chir       Date:  1987

3.  Preoperative chemotherapy in esophageal carcinoma.

Authors:  D P Kelsen
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

Review 4.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

Review 5.  Adjuvant therapies for cancer of the thoracic esophagus.

Authors:  T Nishihira; T Nakano; S Mori
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

6.  Diagnostic rigid and flexible oesophagoscopy in carcinoma of the oesophagus: a comparison.

Authors:  A J Ritchie; J McGuigan; K McManus; H M Stevenson; J R Gibbons
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

Review 7.  Multimodality treatment of cancer arising from Barrett's epithelium.

Authors:  J A Roth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

8.  Carcinoma of the esophagus. Observations of 40 years.

Authors:  E F Parker; H B Gregorie; W H Prioleau; R D Marks; D M Bartles
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

9.  Postoperative pulmonary complications in patients with esophageal cancer.

Authors:  J Scholz; U Steinhöfel; M Dürig; A Prause; H W Bause; K Hamper; J Schulte am Esch
Journal:  Clin Investig       Date:  1993-04

10.  Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia.

Authors:  F H Ellis; S P Gibb; E Watkins
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.